Goldman Sachs Neutral on Medical Technology; COV, NUVA, ZMH Top Ideas
- Market Wrap: Manufacturing Index Rises to Multi-Year Highs; Apple: No Breach in Recent Photo Leak; Merger Monday!
- After-Hours Stock Movers 9/2 (CNQR) (TTPH) (FLEX) Higher; (END) (HELE) (CDW) Lower (more...)
- Dollar General (DG) Boosts Offer for Family Dollar (FDO) to $80/Share
- Apple (AAPL) Issues Media Advisory Related to Celebrity Photo Theft
- Eminence Capital Raises Stake in Zynga (ZNGA) to 5.1%
Goldman Sachs initiates coverage on Medical Technology with a Neutral view. The firm is Bullish on supplies, Neutral on ortho, and Cautious on cardio
- The firm is rating Covidien plc (NYSE: COV) with a Conviction Buy List rating and $52 price target
- NuVasive, Inc. (Nasdaq: NUVA) Buy $40 price target
- Zimmer Holdings Inc. (NYSE: ZMH) Buy $54 price target
- Stryker Corp. (NYSE: SYK) Neutral $54 price target.
- Baxter International Inc. (NYSE: BAX) Neutral $67 price target
- Hospira Inc. (NYSE: HSP) Neutral $51 price target
- Boston Scientific Corporation (NYSE: BSX) Neutral $13 price target
- Medtronic, Inc. (NYSE: MDT) Neutral $43 price target
- Edwards Lifesciences Corp. (NYSE: EW) Netural $79 price target
- St. Jude Medical Inc. (NYSE: STJ) Sell $41 price target
- Becton, Dickinson and Company (NYSE: BDX) Sell $69 price target.
You May Also Be Interested In
- UPDATE: UBS Starts Hoegh LNG Partners LP (HMLP) at Neutral
- BofA/Merrill Lynch Starts Hoegh LNG Partners LP (HMLP) at Buy
- Goldman Sachs Starts Dish (DISH) at CL-Buy; Resumes Telecom, Cable, Satellite, and Towers (VZ) (WIN) (CMCSA) (AMT)
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesGoldman Sachs Conviction Buy List
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!